Navigation Links
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis
Date:10/15/2009

y.

Upon analysis of the primary efficacy results, the mean CFA was greater during treatment with CREON® (82.8%) compared to treatment with placebo (47.4%), which resulted in a significant difference of 35.4% (p < 0.001). Thus, the study met its primary objective and showed a superior efficacy of CREON® over placebo based on the CFA. Treatment-emergent adverse events, which were predominantly gastrointestinal events, were reported in five patients during treatment with CREON® and nine patients during treatment with placebo.

About Exocrine Pancreatic Insufficiency and Pancreatic Enzyme Replacement Therapies

Exocrine pancreatic insufficiency (EPI) is a condition resulting from a deficiency in the production and/or secretion of pancreatic enzymes that are necessary to digest nutrients in food. The safety and efficacy of prior formulations of pancrelipase in pediatric patients with EPI due to CF have been described in the medical literature. Prior formulations of pancrelipase have also demonstrated clinical efficacy in those patients through years of clinical experience. PERTs work in patients with EPI by delivering pancreatic enzymes to the small intestine to help break down fats, proteins and carbohydrates in food, thereby acting as a replacement for digestive enzymes physiologically secreted by the pancreas. EPI can occur as a complication of a variety of diseases or conditions, including CF, pancreatic cancer, gastrointestinal surgery and chronic pancreatitis. Statistics show that more than 80% of CF patients have EPI, which usually develops during the first year of life.

The original products in the pancreatic enzyme drug class pre-date modern FDA regulatory requirements. Over the past two decades, products in this class have been allowed to be marketed as prescription drugs without formal NDA approval. In 2004, the FDA required manufacturers to submit New Drug Applications (NDAs) for all panc
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
2. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
3. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
4. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
5. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
6. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
7. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
8. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
9. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
10. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
11. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Therapeutics to 2020 - Broadened Diagnostic ... Drive Market Growth despite Patent Expirations ... ADHD Therapeutics to 2020 ...
(Date:8/28/2014)... Ohio , Aug. 28, 2014  A ... competition in generics are adding pressure to pharmaceutical, ... resources. Company resources continue to shrink and approval ... This has led companies to look for additional ... commercialization and for keeping approved products on the ...
(Date:8/28/2014)... 28. August 2014 Sequent ... der Patientenrekrutierung für eine IDE-Pivot-Studie („IDE" ... Beurteilung der Sicherheit und Wirksamkeit des ... („WEB") bekanntgegeben. Adam Arthur, MD, Dozent an ... Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt der WEB-IT-Studie, ...
Breaking Medicine Technology:ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 84 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
... European Association for the Study of ... Diabetes Annual Meeting, ... Annual Meeting of the European Association for the Study,of Diabetes demonstrate ... cardiovascular disease in patients with type 2,diabetes. ACTOS is an oral ...
... Therapy, ALEXANDRIA, La., Sept. 18 Life ... NJ, an emerging provider of,groundbreaking medical devices for ... ThermoSuit(R) System has been granted European CE,Mark (Conformite ... indicated, e.g., to induce hypothermia in patients to,preserve ...
Cached Medicine Technology:ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 2ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 3Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System 2
(Date:8/28/2014)... August 28, 2014 Millennium Treatment ... throughout September. This month will be a celebration ... mental health services. Along with other treatment facilities ... helping to spread the word about this national ... honoring the work of treatment and recovery professionals, ...
(Date:8/28/2014)... Nashville, TN (PRWEB) August 28, 2014 ... the insurance industry on the Internet will now have ... Quotes Pros company. In one click this year, some ... presented at http://quotespros.com/life-insurance.html . , The promoted ... the Quotes Pros finder tool represent popular policies. The ...
(Date:8/28/2014)... ABC television stars will join forces this Labor ... Telethon airing Sunday, Aug. 31, 9/8c on ABC television ... awareness to help save and improve the lives of ... tuning into the 2014 telethon to benefit the Muscular ... some of the network’s leading stars, including Alyssa Milano ...
(Date:8/28/2014)... Pittsburgh, PA (PRWEB) August 28, 2014 ... Ready Nutrition announced today a regional partnership designed ... and goal planning for competitive young athletes, scholastic ... , “Our partnership’s Strong Body & Mind Initiative ... that addresses both the physical and mental dynamics ...
(Date:8/28/2014)... San Mateo, CA (PRWEB) August 28, 2014 ... announce that the MRI Technology program is re-accredited for ... Registry of Magnetic Resonance Imaging Technologists (ARMRIT). , ... re-accreditation. We are constantly improving our program to make ... There is a lot of interest in MRI field ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2
... major league pitcher , FRIDAY, Oct. 30 (HealthDay News) -- ... than a second, it curves and then drops, baffling the ... correctly, is one of baseball,s most daunting pitches. For more ... sworn that the ball seems to have a life of ...
... Partnership to scale ... ... for AIDS Relief (PEPFAR), the largest commitment ever by any nation to combat a single ... Ambassador Eric Goosby, U.S. Global AIDS Coordinator, who oversees implementation of PEPFAR , in ...
... Oct. 30 NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY ... antifungal activity in an established pre-clinical infected nail model ... at the 47th Annual Meeting of the Infectious Diseases ... tests both the penetration of the nail as well ...
... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ... INTUNIV (guanfacine) Extended Release Tablets, at a major psychiatric ... study was to assess the change from baseline on ... Long Form (CPRS-R:L) in patients ages 6 to ...
... ,Charles Drew University has ... the university,s long-term, UCLA partnership aimed at reducing the risk of ... The National Institutes of Health, the National Cancer Institute and the ... Cancer Center Partnership. An additional $4.5 million was allocated to ...
... ... Kentucky felt his heart racing after playing Millsaps College homecoming game on Saturday, October 24, ... Jackson, MS (Vocus) ... his heart racing after playing Millsaps College homecoming game on Saturday, October 24, 2009. , ...
Cached Medicine News:Health News:Scientist Throws Curve Into Breaking-Ball Debate 2Health News:Scientist Throws Curve Into Breaking-Ball Debate 3Health News:U.S. President's Emergency Plan for AIDS Relief Joins mHealth Alliance 2Health News:U.S. President's Emergency Plan for AIDS Relief Joins mHealth Alliance 3Health News:NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis 2Health News:NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis 3Health News:NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis 4Health News:INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale 2Health News:INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale 3Health News:Charles Drew University awarded $9.8 million 2Health News:College Middle Line Backer Treated for Wolff Parkinson White Syndrome at Baptist Cardiovascular Services 2Health News:College Middle Line Backer Treated for Wolff Parkinson White Syndrome at Baptist Cardiovascular Services 3
... St. Jude Medical offers the world's ... Pacel bipolar pacing catheters are available in ... a broad range of curve choices and ... Pacing Catheter is indicated for use in ...
Automated slide maker and stainer...
... treadmill has streamlined design, "whisper ... brushless DC motor and direct ... system that operates on standard ... smooth operation, remarkably low motor ...
... Series 2000 Treadmill is advanced in ... The extra-long, 60-inch treadmill surface provides ... patients. The Series 2000 Treadmill ... accommodate severely debilitated patients. Its extremely ...
Medicine Products: